Agoracom: Small Cap Investment - POET Technologies Inc. - Poet is like a Pharma Company in phase III waiting for FDA approval...

Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Reply New Message

Back To Forum List View

sonum

Rank: Treasurer [?]

Points: 1029 [?]

Votes: 110 Score: 1.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Poet is like a Pharma Company in phase III waiting for FDA approval...

posted on Apr 30, 2015 12:22PM

Poet is like a Pharma Company in phase III with a huge portfolio what is waiting for the FDA approval. Read this, change "pharma" by "POET", Novartis by Apple, J&J by Google, and so on. and think about possible POET´s partnership, finantial model, purchasing low-risk options, etc.

http://www.mckinsey.com/insights/health_systems_and_services/new_frontiers_in_pharma_r_and_38d_investment

Any differences??

GLTA

7 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply